Nomad Power Solutions (NMAD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.88, -5.13% vs the prior close of $4.09.
- Volume 96.87K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NMAD slides 5.1% to $3.88. Closed at $3.88, -5.13% vs the prior close of $4.09. Day range $3.85–$4.16, opened at $4.09.
NMAD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NMAD slides 5.1% to $3.88
- Closed at $3.88, -5.13% vs the prior close of $4.09. Day range $3.85–$4.16, opened at $4.09.
- Volume was 96.87K shares, 0.5x its 50-day average of 210.86K — lighter than usual.
- Price is -1.2% vs its 50-day average ($3.93) and -8.8% vs its 200-day average ($4.26).
- 52-week range $2.36–$8.38; today's close sits at 25% of that range, 53.7% below the 52-week high.
Oct 15, 2026 — NMAD jumps 3.5% to $4.09
- Closed at $4.09, +3.54% vs the prior close of $3.95. Day range $3.61–$4.12, opened at $3.96.
- Volume was 296.00K shares, 1.4x its 50-day average of 211.44K.
- Price is +4.1% vs its 50-day average ($3.93) and -3.9% vs its 200-day average ($4.26).
- 52-week range $2.36–$8.38; today's close sits at 29% of that range, 51.2% below the 52-week high.
Oct 14, 2026 — NMAD slides 7.7% to $3.95
- Closed at $3.95, -7.71% vs the prior close of $4.28. Day range $3.95–$4.39, opened at $4.18.
- Volume was 118.70K shares, 0.5x its 50-day average of 225.10K — lighter than usual.
- Price is +0.6% vs its 50-day average ($3.93) and -7.2% vs its 200-day average ($4.26).
- 52-week range $2.36–$8.38; today's close sits at 26% of that range, 52.9% below the 52-week high.
Oct 13, 2026 — NMAD rises 2.6% to $4.28
- Closed at $4.28, +2.64% vs the prior close of $4.17. Day range $4.11–$4.39, opened at $4.11.
- Volume was 401.10K shares, 1.8x its 50-day average of 222.84K.
- Price is +9.1% vs its 50-day average ($3.92) and +0.6% vs its 200-day average ($4.26).
- 52-week range $2.36–$8.38; today's close sits at 32% of that range, 48.9% below the 52-week high.
Oct 12, 2026 — NMAD slides 7.9% to $4.17
- Closed at $4.17, -7.95% vs the prior close of $4.53. Day range $4.12–$4.54, opened at $4.54.
- Volume was 143.70K shares, 0.6x its 50-day average of 235.25K.
- Price is +6.3% vs its 50-day average ($3.92) and -2.0% vs its 200-day average ($4.26).
- 52-week range $2.36–$8.38; today's close sits at 30% of that range, 50.2% below the 52-week high.
Oct 9, 2026 — NMAD jumps 6.1% to $4.53, a 1-month high
- Closed at $4.53, +6.09% vs the prior close of $4.27. Day range $4.28–$4.65, opened at $4.32.
- Volume was 164.90K shares, 0.7x its 50-day average of 243.22K.
- Price is +15.3% vs its 50-day average ($3.93) and +6.5% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 36% of that range, 45.9% below the 52-week high.
Oct 8, 2026 — NMAD rises 0.5% to $4.27
- Closed at $4.27, +0.47% vs the prior close of $4.25. Day range $4.22–$4.43, opened at $4.22.
- Volume was 71.80K shares, 0.3x its 50-day average of 255.16K — lighter than usual.
- Price is +8.9% vs its 50-day average ($3.92) and +0.4% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 32% of that range, 49.0% below the 52-week high.
Oct 7, 2026 — NMAD dips 2.3% to $4.25
- Closed at $4.25, -2.30% vs the prior close of $4.35. Day range $4.22–$4.45, opened at $4.24.
- Volume was 126.20K shares, 0.5x its 50-day average of 259.96K — lighter than usual.
- Price is +8.5% vs its 50-day average ($3.92) and -0.1% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 31% of that range, 49.3% below the 52-week high.
Oct 6, 2026 — NMAD jumps 8.2% to $4.35, a 1-month high
- Closed at $4.35, +8.21% vs the prior close of $4.02. Day range $3.98–$4.40, opened at $3.98.
- Volume was 146.70K shares, 0.6x its 50-day average of 262.97K — lighter than usual.
- Price is +11.0% vs its 50-day average ($3.92) and +2.3% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 33% of that range, 48.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — NMAD dips 2.4% to $4.02
- Closed at $4.02, -2.43% vs the prior close of $4.12. Day range $3.85–$4.12, opened at $4.12.
- Volume was 177.80K shares, 0.7x its 50-day average of 263.23K.
- Price is +2.5% vs its 50-day average ($3.92) and -5.4% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 28% of that range, 52.0% below the 52-week high.
Oct 2, 2026 — NMAD jumps 6.7% to $4.12, a 1-month high
- Closed at $4.12, +6.74% vs the prior close of $3.86. Day range $3.84–$4.19, opened at $3.85.
- Volume was 140.10K shares, 0.5x its 50-day average of 267.12K — lighter than usual.
- Price is +4.6% vs its 50-day average ($3.94) and -3.1% vs its 200-day average ($4.25).
- 52-week range $2.36–$8.38; today's close sits at 29% of that range, 50.8% below the 52-week high.
NMAD latest news & SEC filings
Every SEC filing by or about NMAD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 17, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
:
- Diluted EPS: -$0.16 (prior year -$0.29) (loss narrowed vs Jun 30, 2025)
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 27, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 17, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NMAD
- How much it moves: over the last 20 sessions the average daily move was 4.10% (largest 8.2%). That is a volatile stock.
- Liquidity: about 181.13K shares (≈$702.80K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.88 vs a range of $2.36–$8.38 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 30, 2026; 10-Q Aug 14, 2026.
- Share count: 16.10M shares outstanding (Aug 10, 2026), +253.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NMAD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.09 | 4.16 | 3.85 | 3.88 | 96.87K |
| Oct 15, 2026 | 3.96 | 4.12 | 3.61 | 4.09 | 296.00K |
| Oct 14, 2026 | 4.18 | 4.39 | 3.95 | 3.95 | 118.70K |
| Oct 13, 2026 | 4.11 | 4.39 | 4.11 | 4.28 | 401.10K |
| Oct 12, 2026 | 4.54 | 4.54 | 4.12 | 4.17 | 143.70K |
| Oct 9, 2026 | 4.32 | 4.65 | 4.28 | 4.53 | 164.90K |
| Oct 8, 2026 | 4.22 | 4.43 | 4.22 | 4.27 | 71.80K |
| Oct 7, 2026 | 4.24 | 4.45 | 4.22 | 4.25 | 126.20K |
| Oct 6, 2026 | 3.98 | 4.40 | 3.98 | 4.35 | 146.70K |
| Oct 5, 2026 | 4.12 | 4.12 | 3.85 | 4.02 | 177.80K |
| Oct 2, 2026 | 3.85 | 4.19 | 3.84 | 4.12 | 140.10K |
| Oct 1, 2026 | 3.90 | 4.10 | 3.82 | 3.86 | 153.80K |
| Sep 30, 2026 | 3.71 | 3.96 | 3.60 | 3.93 | 234.60K |
| Sep 29, 2026 | 3.60 | 3.83 | 3.44 | 3.75 | 228.40K |
| Sep 28, 2026 | 3.57 | 3.73 | 3.52 | 3.60 | 107.00K |
| Sep 25, 2026 | 3.61 | 3.86 | 3.56 | 3.58 | 194.80K |
| Sep 24, 2026 | 3.63 | 3.64 | 3.51 | 3.63 | 62.60K |
| Sep 23, 2026 | 3.78 | 3.79 | 3.39 | 3.53 | 278.50K |
| Sep 22, 2026 | 3.73 | 4.01 | 3.73 | 3.82 | 341.50K |
| Sep 21, 2026 | 3.64 | 3.74 | 3.56 | 3.68 | 137.60K |
About Nomad Power Solutions
Nomad Power Solutions (NMAD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BOCA RATON, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1335105.
NMAD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lourdes Felix | Director | Jul 2, 2026 |
| Michael Andrew Holloway | Director | Jul 2, 2026 |
| Stuart D Porter | Director | Jun 1, 2026 |
| Guy Warren Primus | Director | Jul 2, 2026 |
| Geordan Garrett Pursglove | CEO and Chairman of the Board | Jul 2, 2026 |
| Jason David Sawyer | Director | Jul 2, 2026 |
| John Francis Travaglini | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Geordan Garrett Pursglove | CEO and Chairman of the Board | Jul 2, 2026 |
| Peter Stazzone | Chief Financial Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NMAD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-6.08M | -1.26 | $-3.07M |
| Dec 31, 2024 | — | $-3.59M | -1.59 | $-3.16M |
| Dec 31, 2023 | — | $-5.09M | -2.66 | $-4.29M |
| Dec 31, 2022 | — | $-6.31M | -3.99 | $-4.61M |
| Dec 31, 2021 | — | $-6.73M | — | $-4.14M |
Latest balance sheet: total assets $26.65M, total liabilities $1.66M, cash $3.41M (as of Jun 30, 2026).
NMAD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NMAD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.